Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
244 recruiting
Showing 1–20 of 396 trials
Recruiting
Phase 3
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Non-small Cell Lung Cancer (NSCLC)
Astellas Pharma Global Development, Inc.356 enrolled5 locationsNCT07566052
Recruiting
Phase 1Phase 2
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Advanced Solid Tumor
Wigen Biomedicine Technology (Shanghai) Co., Ltd.86 enrolled10 locationsNCT06953323
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled85 locationsNCT06172478
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb990 enrolled281 locationsNCT07221357
Recruiting
Phase 1
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
B-cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.200 enrolled3 locationsNCT04993690
Recruiting
Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Gastric AdenocarcinomaPancreatic AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.398 enrolled46 locationsNCT05365581
Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
DLBCL
Guangzhou Lupeng Pharmaceutical Company LTD.42 enrolledNCT07570017
Recruiting
Phase 2
Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Xuekui Liu40 enrolledNCT07814287
Recruiting
Phase 3
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Metastatic Colorectal Cancer
EMD Serono Research & Development Institute, Inc.1,020 enrolled21 locationsNCT07549412
Recruiting
Phase 1Phase 2
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Nanjing Leads Biolabs Co.,Ltd342 enrolled26 locationsNCT06049290
Recruiting
Phase 1
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
Advanced cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.42 enrolled11 locationsNCT07260708
Recruiting
Phase 3
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb850 enrolled256 locationsNCT07361497
Recruiting
Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast NeoplasmsNeoplasm Metastasis
Eli Lilly and Company800 enrolled346 locationsNCT07174336
Recruiting
Phase 1
A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
Prostate Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.118 enrolledNCT07735377
Recruiting
Phase 1
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Triple-Negative Breast CancerEsophageal CancerPancreatic Cancer+11 more
Eli Lilly and Company420 enrolled38 locationsNCT06465069
Recruiting
Phase 3
A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC
Papillary-Only Non-muscle-invasive Bladder Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.750 enrolledNCT07726992
Recruiting
Phase 4
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic
Eli Lilly and Company150 enrolled50 locationsNCT07218341
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of SY-12321 in Patients With ALK-positive Advanced Malignancies
ALK Positive Advanced Malignancies
Shouyao Holdings (Beijing) Co. LTD330 enrolledNCT07810933
Recruiting
Phase 1Phase 2
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors
Advanced Solid Tumors
Lepu Biopharma Co., Ltd.18 enrolledNCT05688605
Recruiting
Phase 3
SBRT Versus Surgical Resection for Small HCC
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University390 enrolledNCT07381660